Search - tctmd.com

Displaying 81 - 100 of 392

Sort: Relevancy | Date

News Daily News

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Caitlin E. Cox

July 13, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News EuroPCR 2023

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

Shelley Wood

May 17, 2023

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Conference News EHRA 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

Michael O'Riordan

April 25, 2023

News Opinion Fellow Talk

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poornima Mohan, MBChB

March 31, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News ACC 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Shelley Wood

March 10, 2023

News Conference News STS 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

Yael L. Maxwell

February 02, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Advertisement

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content